Back to touchmedicalmedia.com

Delivering medical education for a global audience delivered by expert faculty.
touchIME
Read Time: < 1 min

touchONCOLOGY Official Video Partner at the European Cancer Summit 2022

Copy Link
Published Online: Oct 17th 2022
Article:

touchONCOLOGY is delighted to be the Official Video Partner for the 2022 European Cancer Summit

The 2022 European Cancer Summit is focused on the most important topics in cancer for a wide-ranging discussion focused on delivery and collaboration. The summit has an exciting programme and speaker line-up to discuss the main issues impacting cancer policy, for the benefit of cancer patients, healthcare professionals and all people across Europe.

touchONCOLOGY will cover key highlights and hot topics from the Summit and we will host these videos on the Conference Hub.

Take a look at our content from the European Cancer Summit highlights from previous years here

Sign up to your FREE account today to receive the latest clinical insights, including congress news & coverage, links to the latest education relevant to your specialty, bookmarked articles, journals, and our monthly newsletter.

Please Reach out to find out more about our medical society partnerships.

Share this Article
Related Content In touchIME
touchIME
touchOUTCOMES: Introducing the Learner to Patient Impact Framework
Read Time: 2 mins

The 'Learner-to-Patient Impact Framework' (touchLPI) advances our holistic approach to delivering impactful education that has a positive impact on patient health.

touchIME
JAK inhibitors: A new player for hard-to-treat skin conditions
Read Time: 12 mins

In this episode, Dr William (Bill) Damsky discusses JAK inhibitors' journey from proof-of-concept to treating a wide range of skin conditions, their future impact on rare diseases and the debate around safety.

touchIME
Laying the groundwork for medical breakthroughs: The MPN-RC blueprint
Read Time: 12 mins

In this episode, we speak with Prof. John Mascarenhas, about the coalition's founding, operational mechanics and how their efforts have led to paradigm-shifting therapies in the field.

Trending In touchIME:

touchOUTCOMES: Introducing the Learner to Patient Impact Framework
touchIME
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup